Brief Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Nov 21, 2009; 15(43): 5449-5454
Published online Nov 21, 2009. doi: 10.3748/wjg.15.5449
Figure 1
Figure 1 Neutrophil count response after 1 mo of granulocyte colony stimulating factors administration.
Figure 2
Figure 2 Comparison of treatment duration, premature discontinuation rate, infections rate and sustained virological response (SVR) rate between neutropenic patients treated with G-CSF and untreated non-neutropenic patients.
Figure 3
Figure 3 Incidence of hepatic and systemic autoimmune diseases in neutropenic patients treated with G-CSF and untreated non-neutropenic patients.